BCDA Research and Charts

BCDA - BioCardia Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-07-11)

Last 2.39	Change ⇓ -0.03 (-1.24%)	Volume 173,204
	Open 2.38	High 2.41	Low 2.31

8EMA (Daily) 2.27	40EMA (Daily) 2.22	50EMA (Daily) 2.23	STO (Daily) 72.400	MACD Hist (Daily) 0.081
8EMA (Weekly) 2.225	40EMA (Weekly) 2.25	50EMA (Weekly) 2.22	STO (Weekly) 31.020	MACD Hist (Weekly) -0.014


Company Profile
BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.